Literature DB >> 2322649

Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages--immunohistochemical study of 107 cases.

J D Jacquemier1, J Hassoun, M Torrente, P M Martin.   

Abstract

The purpose of this study was to determine the distribution of ER+ (estrogen receptor) and PR+ (progesterone receptor) epithelial cells in normal mammary tissue or in tissue in contact with or involved in benign or malignant processes. Three important findings emerged from this study. First, a true dissociation was observed between ER+ and PR+ cells in mammary tissue. In premenopausal women some cells express only progesterone receptors. In premenopausal normal tissue, regardless of the menstrual cycle status, 6% of cells are ER+ and 29% PR+. Second, during the menstrual cycle the percentage of positive cells varies. This finding would indicate a change in cell recruitment rather than in intracellular levels. Finally, specific changes in the proportion of positive cells in normal tissue in contact with epithelial proliferations were noted. This finding suggests the possibility of either a diffusible factor or a cellular pathological process spreading beyond areas displaying morphological changes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2322649     DOI: 10.1007/bf01810783

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  35 in total

1.  Predicting response to endocrine therapy in human breast cancer: a hypothesis.

Authors:  K B Horwitz; W L McGuire
Journal:  Science       Date:  1975-08-29       Impact factor: 47.728

2.  [Breast tissue: estrogen receptors. Immunohistochemical and biochemical analysis of normal and hyperplastic tissue and carcinoma in situ. Apropos of 86 cases].

Authors:  J Jacquemier; P H Gandilhon; C Charpin; N Pourreau-Schneider; J Hassoun; P M Martin
Journal:  Bull Cancer       Date:  1987       Impact factor: 1.276

3.  Regulation of estrogen receptor replenishment by progesterone.

Authors:  J H Clark; A J Hsueh; E J Peck
Journal:  Ann N Y Acad Sci       Date:  1977-03-11       Impact factor: 5.691

4.  Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship.

Authors:  D Fabbro; W Küng; W Roos; R Regazzi; U Eppenberger
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

5.  Significance of aromatase activity in human breast cancer.

Authors:  W R Miller; R A Hawkins; A P Forrest
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

6.  Prognostic factors in primary breast cancer.

Authors:  G M Clark; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

7.  Relationships between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast.

Authors:  J D Jacquemier; P H Rolland; D Vague; R Lieutaud; J M Spitalier; P M Martin
Journal:  Cancer       Date:  1982-06-15       Impact factor: 6.860

8.  Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance.

Authors:  S Nicholson; J R Sainsbury; G K Needham; P Chambers; J R Farndon; A L Harris
Journal:  Int J Cancer       Date:  1988-07-15       Impact factor: 7.396

9.  Estradiol and progesterone receptors in human breast fibroadenomas.

Authors:  F Kuttenn; S Fournier; J C Durand; P Mauvais-Jarvis
Journal:  J Clin Endocrinol Metab       Date:  1981-06       Impact factor: 5.958

10.  Aromatase activity in breast adipose tissue from women with benign and malignant breast diseases.

Authors:  J S O'Neill; W R Miller
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

View more
  25 in total

1.  Distinct expression patterns of ER alpha and ER beta in normal human mammary gland.

Authors:  V Speirs; G P Skliris; S E Burdall; P J Carder
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

Review 2.  Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Authors:  David N Danforth
Journal:  Breast Cancer (Auckl)       Date:  2016-08-17

Review 3.  Use of the autopsy to study ontogeny and expression of the estrogen receptor gene in human breast.

Authors:  S A Bartow
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

4.  ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas.

Authors:  Lisa M J Lee; Jiang Cao; Hao Deng; Ping Chen; Zoran Gatalica; Zhao-Yi Wang
Journal:  Anticancer Res       Date:  2008 Jan-Feb       Impact factor: 2.480

5.  Expression of the estrogen receptor gene in developing and adult human breast.

Authors:  M Boyd; R H Hildebrandt; S A Bartow
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 6.  ER re-expression and re-sensitization to endocrine therapies in ER-negative breast cancers.

Authors:  Joeli A Brinkman; Dorraya El-Ashry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-03-05       Impact factor: 2.673

Review 7.  Immunohistochemical studies of early breast cancer evolution.

Authors:  D C Allred; P O'Connell; S A Fuqua; C K Osborne
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 8.  William L. McGuire Memorial Symposium. Estrogen and progestin effects in human breast carcinogenesis.

Authors:  R J King
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 9.  Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis.

Authors:  S Nandi; R C Guzman; J Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

Review 10.  Model of tumor-associated epigenetic changes of HER2, ER, and PgR expression in invasive breast cancer phenotypes.

Authors:  Sven Kurbel
Journal:  Tumour Biol       Date:  2013-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.